Financials Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi

Equities

KLKIM

TREKLKM00025

Commodity Chemicals

Market Closed - Borsa Istanbul 11:09:56 2024-07-05 am EDT 5-day change 1st Jan Change
28.28 TRY +0.86% Intraday chart for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi +2.09% +31.53%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 2,082 5,729 9,890 13,009 -
Enterprise Value (EV) 1 2,082 5,265 9,890 11,565 10,711
P/E ratio 977 x 10.9 x - 11.8 x 9.75 x
Yield - 2.01% - 1.41% 2.48%
Capitalization / Revenue - 2.67 x 2.12 x 2.34 x 1.77 x
EV / Revenue - 2.46 x 2.12 x 2.08 x 1.46 x
EV / EBITDA - 11.7 x 9.73 x 10.5 x 7.51 x
EV / FCF - 31.9 x - 20.6 x -
FCF Yield - 3.13% - 4.86% -
Price to Book - 5.34 x - 5.14 x 3.7 x
Nbr of stocks (in thousands) 460,000 460,000 460,000 460,000 -
Reference price 2 4.525 12.46 21.50 28.28 28.28
Announcement Date 3/1/22 3/2/23 4/17/24 - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales 1 - 2,143 4,668 5,566 7,338
EBITDA 1 - 451.6 1,016 1,100 1,427
EBIT 1 - 421.7 894.6 1,035 1,347
Operating Margin - 19.67% 19.17% 18.6% 18.36%
Earnings before Tax (EBT) 1 - 508 652 1,279 1,569
Net income 1 213.3 506.9 430.4 1,103 1,316
Net margin - 23.65% 9.22% 19.82% 17.93%
EPS 2 0.004630 1.140 - 2.400 2.900
Free Cash Flow 1 - 165 - 562 -
FCF margin - 7.7% - 10.1% -
FCF Conversion (EBITDA) - 36.55% - 51.09% -
FCF Conversion (Net income) - 32.56% - 50.95% -
Dividend per Share 2 - 0.2500 - 0.4000 0.7000
Announcement Date 3/1/22 3/2/23 4/17/24 - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 302.4 555.5 560.9 724.5 602.2 848.1 1,095
EBITDA 1 - 112.8 106.3 157.8 108.1 217.4 304.6
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) 1 - - 107.2 186.8 121.5 289.9 330
Net income 1 71.1 110.3 83.98 241.5 94.03 229.4 244.8
Net margin 23.51% 19.85% 14.97% 33.34% 15.61% 27.04% 22.36%
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 4/21/22 8/9/22 10/18/22 3/2/23 5/1/23 8/9/23 10/20/23
1TRY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt 1 - - - - -
Net Cash position 1 - 464 - 1,444 2,298
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - 165 - 562 -
ROE (net income / shareholders' equity) - 59% - 53% 44%
ROA (Net income/ Total Assets) - 36.4% - 31.3% 26.7%
Assets 1 - 1,391 - 3,524 4,929
Book Value Per Share 2 - 2.330 - 5.500 7.640
Cash Flow per Share - - - - -
Capex - 87.6 - - -
Capex / Sales - 4.09% - - -
Announcement Date 3/1/22 3/2/23 4/17/24 - -
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
28.28 TRY
Average target price
39.06 TRY
Spread / Average Target
+38.12%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. KLKIM Stock
  4. Financials Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi